Biofedora ApS Financials, key figures and credit report
Gross profit 156.0 kDKK FY 2025 +268.7% vs 2024
EBIT 138.0 kDKK FY 2025 +3,712.7% vs 2024
Net debt - 444.9 kDKK FY 2025 +24.4% vs 2024
Quick ratio 7.3 FY 2025 +2.8 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 245.41 | 411.30 | 17.04 | 42.32 | 156.05 |
| Employee benefit expenses | -51.32 | -84.69 | -43.11 | -38.70 | -18.03 |
| EBIT | 194.09 | 326.61 | -26.07 | 3.62 | 138.02 |
| Other financial income | 0.73 | 1.34 | 1.07 | 1.91 | |
| Other financial expenses | -5.82 | -10.33 | -2.07 | -7.63 | -2.55 |
| Pre-tax profit | 188.28 | 317.01 | -26.79 | -2.94 | 137.38 |
| Income taxes | -42.28 | -70.77 | 5.44 | -0.65 | -30.31 |
| Net earnings | 145.99 | 246.23 | -21.35 | -3.59 | 107.07 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 58.73 | 99.01 | 165.27 | 95.82 | 92.87 |
| Inventories total | 58.73 | 99.01 | 165.27 | 95.82 | 92.87 |
| Current trade debtors | 236.62 | 381.72 | 67.69 | 128.53 | 44.84 |
| Current amounts owed by group member comp. | 4.35 | 4.35 | |||
| Current other receivables | 15.20 | 34.52 | |||
| Current deferred tax assets | 25.44 | 32.79 | |||
| Short term receivables total | 236.62 | 381.72 | 108.33 | 200.20 | 49.19 |
| Cash and bank deposits | 749.05 | 672.27 | 827.61 | 596.62 | 448.68 |
| Cash and cash equivalents | 749.05 | 672.27 | 827.61 | 596.62 | 448.68 |
| Balance sheet total (assets) | 1 044.40 | 1 153.01 | 1 101.21 | 892.64 | 590.74 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 66.00 | 66.00 | 66.00 | 66.00 | 66.00 |
| Shares repurchased | 300.00 | 300.00 | |||
| Retained earnings | 282.36 | 428.35 | 674.59 | 353.24 | 349.65 |
| Profit of the financial year | 145.99 | 246.23 | -21.35 | -3.59 | 107.07 |
| Shareholders equity total | 794.35 | 740.59 | 719.24 | 715.65 | 522.72 |
| Non-current liabilities total | |||||
| Current trade creditors | 110.70 | 108.17 | 116.49 | 105.85 | 31.86 |
| Current owed to participating | 146.10 | 200.10 | 7.98 | 3.81 | |
| Short-term deferred tax liabilities | 26.28 | 46.77 | 7.52 | ||
| Other non-interest bearing current liabilities | 113.06 | 111.38 | 65.39 | 63.16 | 24.83 |
| Current liabilities total | 250.04 | 412.42 | 381.98 | 176.99 | 68.02 |
| Balance sheet total (liabilities) | 1 044.40 | 1 153.01 | 1 101.21 | 892.64 | 590.74 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated